Navigation Links
Botox May Prevent Some Migraines
Date:2/15/2010

Small study shows patients with ocular type benefit from treatment

MONDAY, Feb. 15 (HealthDay News) -- Botulinum toxin type A (Botox), the drug that can temporarily erase wrinkles, may also help prevent some types of migraines, a small study suggests.

Specifically, Botox may help reduce the recurrence of those migraines people describe as crushing or eye-popping, otherwise known as ocular migraines. However, the treatment does not appear to work for migraines that are experienced as pressure inside the head, the researchers added.

"In a previous study, neurologists discovered that most patients with imploding and ocular headaches responded to botulinum toxin A injections with a reduction of their headache frequency, while the majority of patients with exploding type migraines did not respond," said lead researcher Dr. Christine C. Kim, a dermatologist in Encino, Calif.

"We tested this hypothesis in a cosmetic dermatology setting, using botulinum toxin A doses that were much lower than what is typically used by headache specialists, and found similar results," she added.

The report is published in the February issue of the Archives of Dermatology.

Kim's group looked at 18 patients who were already going to have Botox injection for cosmetic reasons, but who also suffered from migraines. Among these patients, 10 had the type of migraine described as feeling crushing or eye-popping, like "someone is pushing a finger into an eye."

In addition, nine described their headaches as exploding headaches, feeling like their head is going to explode or split, or pressure is building up. Several patients had more than one type of migraine.

Within three months after Botox treatment, 13 patients saw a reduction in migraine pain. These included 10 with imploding or ocular migraine and three with exploding headaches. The six patients who did not respond to Botox all had exploding migraine.

Patients who responded to Botox saw their migraines reduced from almost seven days a month to less than one day a month. Among those with exploding migraine, headaches were reduced from 11.4 days a month to 9.4 days a month.

Why Botox, which paralyzes muscles, reduces migraine isn't clear, the researchers said. It may work by blocking pain receptors or reducing inflammation, they noted.

"While our results are preliminary, we are hopeful that our findings may eventually help researchers determine how botulinum toxin A injections prevent migraine pain, which patients will respond favorably, and what the proper doses and injection locations should be," Kim said.

The study was funded in part by Allergan Inc., the maker of Botox.

Botox has been tested before as a treatment for migraine, but was found wanting. In 2008, guidelines from the American Academy of Neurology said Botox should not be used to treat migraine because there was no evidence that it was beneficial.

"While Botox is not a first-line therapy for migraine prophylaxis, more research in this area may reveal that it can work to treat a unique portion of the migraine-suffering population," Kim said. "Botox is not considered the standard of care for preventing migraines, but it may be an alternative for some patients who do not respond to standard prophylactic medications."

Dr. Richard B. Lipton, vice chairman of neurology and director of the Montefiore Headache Center at the Albert Einstein College of Medicine in New York City, agreed: "Some migraine patients respond to treatment with botulinum toxin very dramatically, while others do not respond."

"Identifying the migraine patients who respond to toxin has long been a holy grail in headache medicine," he added.

Though this study is small, when combined with other evidence, it strongly supports the idea that patients with imploding headache respond to Botox treatment, Lipton said.

"Two recent double-blind studies show that patients with chronic migraine, with headaches 15 or more days per month, also respond to treatment with botulinum toxin," he added. Lipton noted that he has also received funding from Allergan.

Another expert, Dr. Gretchen E. Tietjen, chairwoman of neurology and director of the Headache Treatment and Research Program at the University of Toledo Medical Center in Ohio, said that while Botox is not a first-line treatment, she does refer some of her migraine patients.

"Maybe 50 percent of the people I refer for Botox tell me they really think it helped them," she said. "It's a select group of patients I refer. Usually, it's people where I have tried every medicine I can think of and it didn't work."

Tietjen noted that many insurance companies won't pay for Botox treatment for migraine.

More information

For more information on migraine, visit the U.S. National Library of Medicine.



SOURCES: Christine C. Kim, M.D., dermatologist, Encino, Calif.; Richard B. Lipton, M.D., vice chairman, neurology, and director, Montefiore Headache Center, Albert Einstein College of Medicine, New York City; Gretchen E. Tietjen, M.D., chairwoman, neurology, and director, Headache Treatment and Research Program, University of Toledo Medical Center, Ohio; February 2010 Archives of Dermatology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Book Reveals How Qigong Could Be The Eastern Answer To Botox
2. A Study by Celibre Medical Corporation Shows Botox Injections to be the Most Desirable Cosmetic Procedure in Southern California
3. New Guidelines Suggest Botox for Cerebral Palsy
4. Physicians Coalition for Injectable Safety Urges Reporting of Suspected Illegal Solicitation or Use of Botox, Restylane, Radiesse and Others
5. NYCs Only Walk-in Botox Clinic, SmoothMED - Where Boytox Hits Men Right in the Brow!
6. Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative
7. Look Great this Summer, Phoenix! BOTOX and Juvederm Offered at Beauty Open House with Dr. Heidi Regenass, June 25th
8. Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
9. Does Botox(R) Finally Have Competition?
10. Botox injections can significantly improve quality of life for people with overactive bladders
11. Competing With Botox - What Is On the Horizon?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes ... a mock evacuation of the facility as part of a disaster drill on October ... Hose EMS and Shelton City Emergency Manager, as well as the Connecticut Long ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology: